nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—Estradiol valerate/Dienogest—prostate cancer	0.352	1	CrCtD
Nandrolone phenpropionate—AR—prostate cancer	0.0923	0.545	CbGaD
Nandrolone phenpropionate—CYP19A1—prostate cancer	0.0773	0.456	CbGaD
Nandrolone phenpropionate—AR—Nilutamide—prostate cancer	0.0644	0.315	CbGbCtD
Nandrolone phenpropionate—AR—Bicalutamide—prostate cancer	0.0644	0.315	CbGbCtD
Nandrolone phenpropionate—AR—Flutamide—prostate cancer	0.0534	0.261	CbGbCtD
Nandrolone phenpropionate—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.0353	0.156	CrCrCtD
Nandrolone phenpropionate—Nandrolone decanoate—Estradiol valerate/Dienogest—prostate cancer	0.03	0.132	CrCrCtD
Nandrolone phenpropionate—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.0267	0.118	CrCrCtD
Nandrolone phenpropionate—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.0261	0.115	CrCrCtD
Nandrolone phenpropionate—Testosterone—Abiraterone—prostate cancer	0.0249	0.11	CrCrCtD
Nandrolone phenpropionate—AR—Estradiol—prostate cancer	0.0222	0.108	CbGbCtD
Nandrolone phenpropionate—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.014	0.062	CrCrCtD
Nandrolone phenpropionate—Etonogestrel—Ethinyl Estradiol—prostate cancer	0.0132	0.0585	CrCrCtD
Nandrolone phenpropionate—Norelgestromin—Ethinyl Estradiol—prostate cancer	0.0125	0.0554	CrCrCtD
Nandrolone phenpropionate—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.0104	0.0458	CrCrCtD
Nandrolone phenpropionate—Testosterone—Estramustine—prostate cancer	0.0104	0.0458	CrCrCtD
Nandrolone phenpropionate—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00833	0.0368	CrCrCtD
Nandrolone phenpropionate—Testosterone—Estrone—prostate cancer	0.00823	0.0364	CrCrCtD
Nandrolone phenpropionate—Testosterone—Estradiol—prostate cancer	0.00624	0.0276	CrCrCtD
Nandrolone phenpropionate—CYP19A1—semen—prostate cancer	0.00311	0.233	CbGeAlD
Nandrolone phenpropionate—AR—penis—prostate cancer	0.00289	0.216	CbGeAlD
Nandrolone phenpropionate—AR—semen—prostate cancer	0.00275	0.206	CbGeAlD
Nandrolone phenpropionate—CYP19A1—prostate gland—prostate cancer	0.00078	0.0583	CbGeAlD
Nandrolone phenpropionate—AR—prostate gland—prostate cancer	0.00069	0.0517	CbGeAlD
Nandrolone phenpropionate—AR—seminal vesicle—prostate cancer	0.000584	0.0437	CbGeAlD
Nandrolone phenpropionate—AR—epithelium—prostate cancer	0.000507	0.038	CbGeAlD
Nandrolone phenpropionate—AR—renal system—prostate cancer	0.00047	0.0352	CbGeAlD
Nandrolone phenpropionate—AR—urethra—prostate cancer	0.000462	0.0346	CbGeAlD
Nandrolone phenpropionate—CYP19A1—testis—prostate cancer	0.000343	0.0257	CbGeAlD
Nandrolone phenpropionate—AR—testis—prostate cancer	0.000304	0.0228	CbGeAlD
Nandrolone phenpropionate—CYP19A1—lymph node—prostate cancer	0.000249	0.0186	CbGeAlD
Nandrolone phenpropionate—AR—lymph node—prostate cancer	0.00022	0.0165	CbGeAlD
Nandrolone phenpropionate—Levonorgestrel—SRD5A1—prostate cancer	0.000158	0.0896	CrCbGaD
Nandrolone phenpropionate—Gestodene—CYP3A5—prostate cancer	8.08e-05	0.0457	CrCbGaD
Nandrolone phenpropionate—Testosterone Propionate—CYP17A1—prostate cancer	7.96e-05	0.045	CrCbGaD
Nandrolone phenpropionate—Testosterone—CYP3A43—prostate cancer	7.61e-05	0.043	CrCbGaD
Nandrolone phenpropionate—Etonogestrel—SHBG—prostate cancer	7.58e-05	0.0429	CrCbGaD
Nandrolone phenpropionate—Nandrolone decanoate—AR—prostate cancer	7.07e-05	0.04	CrCbGaD
Nandrolone phenpropionate—Ethynodiol—ESR1—prostate cancer	6.96e-05	0.0394	CrCbGaD
Nandrolone phenpropionate—Testosterone Propionate—COMT—prostate cancer	6.49e-05	0.0367	CrCbGaD
Nandrolone phenpropionate—Estradiol valerate/Dienogest—CYP3A4—prostate cancer	6.39e-05	0.0361	CrCbGaD
Nandrolone phenpropionate—Norgestimate—ESR1—prostate cancer	5.92e-05	0.0335	CrCbGaD
Nandrolone phenpropionate—Nandrolone decanoate—CYP19A1—prostate cancer	5.92e-05	0.0335	CrCbGaD
Nandrolone phenpropionate—Levonorgestrel—SHBG—prostate cancer	5.36e-05	0.0303	CrCbGaD
Nandrolone phenpropionate—Etonogestrel—ESR1—prostate cancer	5.12e-05	0.029	CrCbGaD
Nandrolone phenpropionate—Testosterone Propionate—AR—prostate cancer	4.84e-05	0.0273	CrCbGaD
Nandrolone phenpropionate—Levonorgestrel—AR—prostate cancer	4.7e-05	0.0266	CrCbGaD
Nandrolone phenpropionate—Norethindrone—SHBG—prostate cancer	4.35e-05	0.0246	CrCbGaD
Nandrolone phenpropionate—Levonorgestrel—CYP19A1—prostate cancer	3.94e-05	0.0223	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP17A1—prostate cancer	3.65e-05	0.0207	CrCbGaD
Nandrolone phenpropionate—Levonorgestrel—ESR1—prostate cancer	3.62e-05	0.0205	CrCbGaD
Nandrolone phenpropionate—Progesterone—SLC22A3—prostate cancer	3.49e-05	0.0197	CrCbGaD
Nandrolone phenpropionate—Norethindrone—CYP3A5—prostate cancer	3.46e-05	0.0196	CrCbGaD
Nandrolone phenpropionate—Testosterone—SLC22A3—prostate cancer	3.3e-05	0.0186	CrCbGaD
Nandrolone phenpropionate—Etonogestrel—CYP3A4—prostate cancer	2.61e-05	0.0148	CrCbGaD
Nandrolone phenpropionate—Progesterone—SHBG—prostate cancer	2.53e-05	0.0143	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP1B1—prostate cancer	2.53e-05	0.0143	CrCbGaD
Nandrolone phenpropionate—Progesterone—SLC22A1—prostate cancer	2.5e-05	0.0141	CrCbGaD
Nandrolone phenpropionate—Testosterone—SHBG—prostate cancer	2.39e-05	0.0135	CrCbGaD
Nandrolone phenpropionate—Testosterone—CYP1B1—prostate cancer	2.39e-05	0.0135	CrCbGaD
Nandrolone phenpropionate—Testosterone—SLC22A1—prostate cancer	2.36e-05	0.0134	CrCbGaD
Nandrolone phenpropionate—Norethindrone—CYP2C19—prostate cancer	2.36e-05	0.0133	CrCbGaD
Nandrolone phenpropionate—Progesterone—AR—prostate cancer	2.22e-05	0.0126	CrCbGaD
Nandrolone phenpropionate—Testosterone—AR—prostate cancer	2.1e-05	0.0119	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP3A5—prostate cancer	2.02e-05	0.0114	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP2A6—prostate cancer	1.95e-05	0.011	CrCbGaD
Nandrolone phenpropionate—Testosterone—CYP3A5—prostate cancer	1.91e-05	0.0108	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ATM—prostate cancer	1.89e-05	0.000584	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—prostate cancer	1.89e-05	0.000582	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	1.88e-05	0.000579	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—prostate cancer	1.88e-05	0.000579	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.87e-05	0.000576	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—prostate cancer	1.87e-05	0.000575	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.86e-05	0.000575	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TBX5—prostate cancer	1.86e-05	0.000574	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—CYP3A4—prostate cancer	1.85e-05	0.0105	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BAD—prostate cancer	1.83e-05	0.000565	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	1.82e-05	0.000562	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	1.81e-05	0.000558	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	1.8e-05	0.000555	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.77e-05	0.000544	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP19A1—prostate cancer	1.76e-05	0.00994	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—prostate cancer	1.76e-05	0.000541	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	1.73e-05	0.000535	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF3H—prostate cancer	1.73e-05	0.000533	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ESR1—prostate cancer	1.71e-05	0.00967	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.71e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—prostate cancer	1.7e-05	0.000522	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.69e-05	0.000521	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	1.68e-05	0.000516	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—prostate cancer	1.65e-05	0.000508	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PSAT1—prostate cancer	1.64e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TST—prostate cancer	1.64e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADI1—prostate cancer	1.64e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CBR1—prostate cancer	1.64e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CSAD—prostate cancer	1.64e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GRHL1—prostate cancer	1.64e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—prostate cancer	1.63e-05	0.000504	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—prostate cancer	1.63e-05	0.000501	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MDM2—prostate cancer	1.63e-05	0.000501	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NCOA2—prostate cancer	1.62e-05	0.000499	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.61e-05	0.000495	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.59e-05	0.000489	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.58e-05	0.000485	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.57e-05	0.000483	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PARP1—prostate cancer	1.56e-05	0.000482	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CKMT2—prostate cancer	1.53e-05	0.000471	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UGT2B17—prostate cancer	1.53e-05	0.000471	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GRHPR—prostate cancer	1.53e-05	0.000471	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UGT2B15—prostate cancer	1.53e-05	0.000471	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.51e-05	0.000466	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—NR3C1—prostate cancer	1.51e-05	0.00852	CrCbGaD
Nandrolone phenpropionate—Norethindrone—CYP3A4—prostate cancer	1.5e-05	0.00847	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.49e-05	0.00046	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR2—prostate cancer	1.48e-05	0.000457	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.48e-05	0.000456	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.47e-05	0.000453	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—prostate cancer	1.45e-05	0.000448	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.44e-05	0.000444	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PGAM2—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MBTPS1—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAGLU—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM3—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AOX1—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—RFK—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SULT2B1—prostate cancer	1.44e-05	0.000443	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—prostate cancer	1.42e-05	0.000437	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.42e-05	0.000437	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—prostate cancer	1.42e-05	0.000436	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TET2—prostate cancer	1.41e-05	0.000435	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MBD2—prostate cancer	1.41e-05	0.000435	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.4e-05	0.000433	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	1.4e-05	0.000432	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—prostate cancer	1.4e-05	0.000431	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPL12—prostate cancer	1.38e-05	0.000426	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP2C19—prostate cancer	1.37e-05	0.00776	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP1A1—prostate cancer	1.37e-05	0.00773	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.37e-05	0.000421	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—prostate cancer	1.37e-05	0.000421	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.37e-05	0.000421	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NCOA1—prostate cancer	1.37e-05	0.000421	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AMACR—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP3A43—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DEGS1—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT1—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SRD5A2—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.35e-05	0.000415	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.34e-05	0.000413	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.33e-05	0.00041	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.33e-05	0.000409	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EP300—prostate cancer	1.3e-05	0.000402	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD17B1—prostate cancer	1.3e-05	0.0004	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.3e-05	0.0004	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—RXRA—prostate cancer	1.3e-05	0.0004	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.3e-05	0.0004	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP2C19—prostate cancer	1.3e-05	0.00734	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.3e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP1A1—prostate cancer	1.29e-05	0.00731	CrCbGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF3A—prostate cancer	1.27e-05	0.000391	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—EP300—prostate cancer	1.27e-05	0.000391	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—prostate cancer	1.25e-05	0.000386	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.25e-05	0.000385	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.24e-05	0.000383	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	1.23e-05	0.00038	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.23e-05	0.000379	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.23e-05	0.000379	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—prostate cancer	1.22e-05	0.000375	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	1.21e-05	0.000372	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.21e-05	0.000371	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.2e-05	0.000371	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—prostate cancer	1.2e-05	0.00037	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—VDR—prostate cancer	1.18e-05	0.000362	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—prostate cancer	1.18e-05	0.000362	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.17e-05	0.000362	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.17e-05	0.000361	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.16e-05	0.000358	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—B4GALT4—prostate cancer	1.16e-05	0.000357	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HPGD—prostate cancer	1.16e-05	0.000357	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—prostate cancer	1.14e-05	0.00035	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.13e-05	0.00035	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.13e-05	0.000349	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EP300—prostate cancer	1.12e-05	0.000346	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—prostate cancer	1.11e-05	0.000342	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TNFRSF21—prostate cancer	1.09e-05	0.000336	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.08e-05	0.000333	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—DNMT3B—prostate cancer	1.07e-05	0.00033	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	1.06e-05	0.000327	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP7B1—prostate cancer	1.06e-05	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTAP—prostate cancer	1.06e-05	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR3C1—prostate cancer	1.06e-05	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.05e-05	0.000324	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—prostate cancer	1.05e-05	0.000323	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPL10—prostate cancer	1.05e-05	0.000323	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.04e-05	0.000319	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SULT1E1—prostate cancer	1.03e-05	0.000318	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SRD5A1—prostate cancer	1.03e-05	0.000318	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HIST1H2BG—prostate cancer	1.03e-05	0.000317	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.02e-05	0.000315	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1e-05	0.000309	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HIST1H4H—prostate cancer	9.94e-06	0.000306	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NPPA—prostate cancer	9.94e-06	0.000306	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARA—prostate cancer	9.92e-06	0.000306	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.87e-06	0.000304	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACSL4—prostate cancer	9.85e-06	0.000303	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD17B3—prostate cancer	9.85e-06	0.000303	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MED12—prostate cancer	9.78e-06	0.000301	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—prostate cancer	9.77e-06	0.000301	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	9.56e-06	0.000295	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ARG2—prostate cancer	9.44e-06	0.000291	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UMPS—prostate cancer	9.44e-06	0.000291	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PHGDH—prostate cancer	9.44e-06	0.000291	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	9.41e-06	0.00029	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	9.39e-06	0.000289	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	9.39e-06	0.000289	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—prostate cancer	9.33e-06	0.000287	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LDHB—prostate cancer	9.26e-06	0.000285	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	9.2e-06	0.000284	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP3A5—prostate cancer	9.09e-06	0.00028	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	9.03e-06	0.000278	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR1—prostate cancer	8.99e-06	0.000277	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PDHA1—prostate cancer	8.78e-06	0.00027	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UCP3—prostate cancer	8.78e-06	0.00027	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TCN2—prostate cancer	8.78e-06	0.00027	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA3—prostate cancer	8.78e-06	0.00027	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP3A4—prostate cancer	8.73e-06	0.00494	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	8.69e-06	0.000268	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD3B1—prostate cancer	8.37e-06	0.000258	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC22A3—prostate cancer	8.37e-06	0.000258	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—prostate cancer	8.32e-06	0.000256	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPS19—prostate cancer	8.31e-06	0.000256	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP3A4—prostate cancer	8.25e-06	0.00467	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.12e-06	0.00025	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA4—prostate cancer	8.03e-06	0.000247	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TBXAS1—prostate cancer	8.03e-06	0.000247	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—prostate cancer	8.02e-06	0.000247	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	7.99e-06	0.000246	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—DNMT1—prostate cancer	7.95e-06	0.000245	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CREBBP—prostate cancer	7.88e-06	0.000243	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—prostate cancer	7.88e-06	0.000243	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.84e-06	0.000242	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA2—prostate cancer	7.82e-06	0.000241	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NCOA2—prostate cancer	7.8e-06	0.00024	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	7.73e-06	0.000238	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCG5—prostate cancer	7.73e-06	0.000238	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SULT1A1—prostate cancer	7.73e-06	0.000238	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EZH2—prostate cancer	7.7e-06	0.000237	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA1—prostate cancer	7.55e-06	0.000233	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PARP1—prostate cancer	7.53e-06	0.000232	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD3B2—prostate cancer	7.46e-06	0.00023	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTO1—prostate cancer	7.46e-06	0.00023	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT2—prostate cancer	7.46e-06	0.00023	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SERPINE1—prostate cancer	7.39e-06	0.000228	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.17e-06	0.000221	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLCB2—prostate cancer	7.15e-06	0.00022	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LRP2—prostate cancer	7.15e-06	0.00022	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2C18—prostate cancer	7.15e-06	0.00022	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPA1A—prostate cancer	7.13e-06	0.00022	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR2—prostate cancer	7.13e-06	0.00022	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—P4HB—prostate cancer	7.02e-06	0.000216	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC22A1—prostate cancer	6.82e-06	0.00021	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	6.78e-06	0.000209	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.75e-06	0.000208	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SULT2A1—prostate cancer	6.65e-06	0.000205	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NCOA1—prostate cancer	6.57e-06	0.000203	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MED12—prostate cancer	6.54e-06	0.000202	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.53e-06	0.000201	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GNG5—prostate cancer	6.49e-06	0.0002	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NCOA3—prostate cancer	6.25e-06	0.000193	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RXRA—prostate cancer	6.25e-06	0.000193	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.14e-06	0.000189	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HPGDS—prostate cancer	5.97e-06	0.000184	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2C19—prostate cancer	5.93e-06	0.000183	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTT1—prostate cancer	5.79e-06	0.000178	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACHE—prostate cancer	5.79e-06	0.000178	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SIRT1—prostate cancer	5.75e-06	0.000177	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2A6—prostate cancer	5.72e-06	0.000176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.7e-06	0.000176	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—VDR—prostate cancer	5.66e-06	0.000174	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKR1C3—prostate cancer	5.56e-06	0.000171	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRKACB—prostate cancer	5.53e-06	0.000171	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP17A1—prostate cancer	5.48e-06	0.000169	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.4e-06	0.000166	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NCOA2—prostate cancer	5.22e-06	0.000161	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ERCC2—prostate cancer	5.18e-06	0.00016	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR3C1—prostate cancer	5.1e-06	0.000157	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A5—prostate cancer	4.98e-06	0.000153	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2E1—prostate cancer	4.86e-06	0.00015	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NQO1—prostate cancer	4.81e-06	0.000148	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARA—prostate cancer	4.78e-06	0.000147	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TH—prostate cancer	4.74e-06	0.000146	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.71e-06	0.000145	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP3A4—prostate cancer	4.69e-06	0.000145	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—prostate cancer	4.67e-06	0.000144	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.67e-06	0.000144	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1B1—prostate cancer	4.61e-06	0.000142	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GGT1—prostate cancer	4.46e-06	0.000138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NCOA1—prostate cancer	4.4e-06	0.000136	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR1—prostate cancer	4.33e-06	0.000133	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—RXRA—prostate cancer	4.18e-06	0.000129	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.07e-06	0.000125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COMT—prostate cancer	4.03e-06	0.000124	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTP1—prostate cancer	4.01e-06	0.000124	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ITPR1—prostate cancer	3.95e-06	0.000122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.88e-06	0.00012	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CREBBP—prostate cancer	3.79e-06	0.000117	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMS—prostate cancer	3.73e-06	0.000115	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—prostate cancer	3.69e-06	0.000114	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LPL—prostate cancer	3.62e-06	0.000111	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SERPINE1—prostate cancer	3.56e-06	0.00011	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A1—prostate cancer	3.49e-06	0.000108	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ERCC2—prostate cancer	3.46e-06	0.000107	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—prostate cancer	3.26e-06	0.0001	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARA—prostate cancer	3.2e-06	9.85e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAV1—prostate cancer	3e-06	9.26e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.87e-06	8.85e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CG—prostate cancer	2.74e-06	8.43e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—INS—prostate cancer	2.59e-06	7.98e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CREBBP—prostate cancer	2.54e-06	7.82e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CD—prostate cancer	2.41e-06	7.41e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NOS3—prostate cancer	2.27e-06	7e-05	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—prostate cancer	2.25e-06	6.94e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CB—prostate cancer	2.1e-06	6.46e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—prostate cancer	2.08e-06	6.4e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—prostate cancer	1.81e-06	5.58e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EP300—prostate cancer	1.73e-06	5.33e-05	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—prostate cancer	1.56e-06	4.81e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—prostate cancer	1.28e-06	3.94e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—prostate cancer	1.04e-06	3.22e-05	CbGpPWpGaD
